Colloids in the intensive care unit

American Journal of Health-System Pharmacy

Volumn 69, Issue 19, 2012, Pages 1635-1642

  Kruer, Rachel M ^a   Ensor, Christopher R ^b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; DEXTRAN; HETASTARCH; SODIUM CHLORIDE;

BLOOD VOLUME; BURN; CARDIOPULMONARY BYPASS; COLLOID; COST BENEFIT ANALYSIS; CRYSTALLOID; FLUID RESUSCITATION; INTENSIVE CARE; INTENSIVE CARE UNIT; MORTALITY; NERVOUS SYSTEM INJURY; PRIORITY JOURNAL; REVIEW; SEPSIS; TRAUMATIC BRAIN INJURY; URINE VOLUME;

EID: 84867383761     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp110414     Document Type: Review

References (32)

1. Rivers E, Nguyen B, Havstad S et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001; 345:1368-77.
2. Dellinger R, Levy MM, Carlet JM et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008; 36:296-327.
3. American Thoracic Society. Evidence-based colloid use in the critically ill: American Thoracic Society consensus statement. Am J Respir Crit Care Med. 2004; 170:1247-59.
4. SAFE study investigators. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med. 2007; 357:874-84.
5. SAFE study investigators. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med. 2011; 37:89-96.
6. Delaney AP, Dan A, McCaffrey J et al. The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and meta-analysis. Crit Care Med. 2011; 39:386-91.
7. Perel P, Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev. 2011; 3:CD000567.
8. Cochran A, Morris SE, Edelman LS et al. Burn patient characteristics and outcomes following resuscitation with albumin. Burns. 2007; 33:25-30. (Pubitemid 46073459)
9. Vlachou E, Gosling P, Moiemen NS. Hydroxyethylstarch supplementation in burn resuscitation - a prospective randomised controlled trial. Burns. 2010; 36:984-91.
10. Perner A, Haase N, Gottormsen AB et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med. 2012; 367:124-34. [Erratum, N Engl J Med. 2012; 367:481.]
11. Beck R, Bertolino S, Abbott SE et al. Modulation of arachidonic acid release and membrane fluidity by albumin in vascular smooth muscle and endothelial cells. Circ Res. 1998; 83:923-31. (Pubitemid 28503081)
12. Nielson VG, Tan S, Brix AE et al. Hextend (hetastarch solution) decreases multiple organ injury and xanthine oxidase release after hepatoenteric ischemia-reperfusion in rabbits. Crit Care Med. 1997; 25:1565-74. (Pubitemid 27391488)
13. McCandless BK, Powers MR, Cooper JA et al. Effect of albumin on hydraulic conductivity of pulmonary artery endothelial monolayers. Am J Physiol. 1991; 260:L571-6.
14. Horstick G, Lauterbach M, Kempf T et al. Early albumin infusion improves global and local hemodynamics and reduces inflammatory response in hemorrhagic shock. Crit Care Med. 2002; 30:851-5. (Pubitemid 34297807)
15. Schortgen F, Girou E, Deye N et al., for the CRYCO Study Group. The risk associated with hyperoncotic colloids in patients with shock. Intensive Care Med. 2008; 34:2157-68.
16. Rioux JP, Lessard M, De Bortoli B et al. Pentastarch 10% (250 kDa/0.45) is an independent risk factor of acute kidney injury following cardiac surgery. Crit Care Med. 2009; 37:1293-8.
17. Brunkhorst FM, Engel C, Bloos F et al., for the German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008; 358:125-39.
18. De Jonge E, Levi M. Effects of different plasma substitutes on blood coagulation: a comparative review. Crit Care Med. 2001; 29:1261-7. (Pubitemid 32554345)
19. Cope JT, Banks D, Mauney MC et al. Intraoperative hetastarch infusion impairs hemostasis after cardiac operations. Ann Thorac Surg. 1997; 63:78-83. (Pubitemid 27039036)
20. SAFE study investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004; 350:2247-56.
21. Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ. 1998; 317:235-40.
22. Miller BE, Levy JH. The inflammatory response to cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 1997; 11:355-66. (Pubitemid 27214906)
23. Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg. 2002; 21:232-44. (Pubitemid 34135370)
24. Sedrakyan A, Gondek K, Paltiel D et al. Volume expansion with albumin decreases mortality after coronary artery bypass graft surgery. Chest. 2003; 123:1853-7. (Pubitemid 36706704)
25. Russell JA, Navickis RJ, Wilkes MM. Albumin versus crystalloid for pump priming in cardiac surgery: meta-analysis of controlled trials. J Cardiothorac Vasc Anesth. 2004; 18:429-37.
26. Wilkes MM, Navickis RJ, Sibbald WJ. Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a meta-analysis of postoperative bleeding. Ann Thorac Surg. 2001; 72:527-34. (Pubitemid 32727162)
27. Niemi TT, Suojaranta-Ylinen RT, Kukkonen SI et al. Gelatin and hydroxyethyl starch, but not albumin, impair hemostasis after cardiac surgery. Anesth Analg. 2006; 102:998-1006.
28. Martin GS, Moss M, Wheeler AP et al. A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Crit Care Med. 2005; 33:1681-7. (Pubitemid 41153690)
29. ClinicalTrials.gov, National Institutes of Health. Volume Replacement With Albumin in Severe Sepsis (ALBIOS). www.clinicaltrials.gov/ct2/show/ NCT00707122 (accessed 2012 Jun 28).
30. ClinicalTrials.gov, National Institutes of Health. Lactated Ringer Versus Albumin in Early Sepsis Therapy (RASP). www. clinicaltrials.gov/ct2/show/ NCT01337934 (accessed 2012 Jun 28).
31. ClinicalTrials.gov, National Institutes of Health. Efficacy and Safety of Colloids Versus Crystalloids for Fluid Resuscitation in Critically Ill Patients. www.clinical tr ials.gov/ct2/show/NCT00318942 (accessed 2012 Jun 28).
32. ClinicalTrials.gov, National Institutes of Health. Early Albumin Resuscitation During Septic Shock. www.clinicaltrials.gov/ct2/show/NCT00327704 (accessed 2012 Jun 28).